BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15735865)

  • 1. Malignant ectomesenchymoma in the wrist of a child: case report and review of the literature.
    Oppenheimer O; Athanasian E; Meyers P; Antonescu CR; Gorlick R
    Int J Surg Pathol; 2005 Jan; 13(1):113-6. PubMed ID: 15735865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
    Grier HE; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Miser JS
    N Engl J Med; 2003 Feb; 348(8):694-701. PubMed ID: 12594313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of chemotherapy in the treatment of infantile fibrosarcoma.
    Shetty AK; Yu LC; Gardner RV; Warrier RP
    Med Pediatr Oncol; 1999 Oct; 33(4):425-7. PubMed ID: 10491560
    [No Abstract]   [Full Text] [Related]  

  • 4. Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors.
    Wexler LH; DeLaney TF; Tsokos M; Avila N; Steinberg SM; Weaver-McClure L; Jacobson J; Jarosinski P; Hijazi YM; Balis FM; Horowitz ME
    Cancer; 1996 Aug; 78(4):901-11. PubMed ID: 8756388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.
    Kushner BH; Meyers PA; Gerald WL; Healey JH; La Quaglia MP; Boland P; Wollner N; Casper ES; Aledo A; Heller G
    J Clin Oncol; 1995 Nov; 13(11):2796-804. PubMed ID: 7595741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
    Hawkins DS; Felgenhauer J; Park J; Kreissman S; Thomson B; Douglas J; Rowley SD; Gooley T; Sanders JE; Pendergrass TW
    Cancer; 2002 Sep; 95(6):1354-65. PubMed ID: 12216105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic malignant transformation of teratoma to primitive neuroectodermal tumor (PNET): results with PNET-based chemotherapy.
    Al-Hader AA; Jain A; Al-Nasrallah N; Einhorn LH
    Am J Clin Oncol; 2015 Aug; 38(4):364-6. PubMed ID: 23799289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
    Miser JS; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Grier HE
    J Clin Oncol; 2004 Jul; 22(14):2873-6. PubMed ID: 15254055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.
    Kushner BH; Meyers PA
    J Clin Oncol; 2001 Feb; 19(3):870-80. PubMed ID: 11157041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.
    Navid F; Santana VM; Billups CA; Merchant TE; Furman WL; Spunt SL; Cain AM; Rao BN; Hale GA; Pappo AS
    Cancer; 2006 Apr; 106(8):1846-56. PubMed ID: 16541446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
    Paulussen M; Craft AW; Lewis I; Hackshaw A; Douglas C; Dunst J; Schuck A; Winkelmann W; Köhler G; Poremba C; Zoubek A; Ladenstein R; van den Berg H; Hunold A; Cassoni A; Spooner D; Grimer R; Whelan J; McTiernan A; Jürgens H;
    J Clin Oncol; 2008 Sep; 26(27):4385-93. PubMed ID: 18802150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infantile malignant mesenchymoma: limb salvage therapy.
    Serivinyayut S; Pathomvanich A; Singhapakdi S
    J Med Assoc Thai; 1991 Dec; 74(12):683-6. PubMed ID: 1813594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood hepatic mesenchymoma: successful treatment with surgery and multiple-agent chemotherapy.
    Ware R; Friedman HS; Filston HC; Chaffee S; Kurtzberg J; Kinney TR; Falletta JM
    Med Pediatr Oncol; 1988; 16(1):62-5. PubMed ID: 3340065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors: the Bambino Gesù Children's Hospital experience.
    Milano GM; Cozza R; Ilari I; De Sio L; Boldrini R; Jenkner A; De Ioris M; Inserra A; Dominici C; Donfrancesco A
    Cancer; 2006 Apr; 106(8):1838-45. PubMed ID: 16532434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Durable complete response to chemotherapy in an infant with a clival chordoma.
    Al-Rahawan MM; Siebert JD; Mitchell CS; Smith SD
    Pediatr Blood Cancer; 2012 Aug; 59(2):323-5. PubMed ID: 21922644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: a report from the Children's Oncology Group.
    Arndt CA; Hawkins DS; Meyer WH; Sencer SF; Neglia JP; Anderson JR
    Pediatr Blood Cancer; 2008 Jan; 50(1):33-6. PubMed ID: 17091486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive posttreatment ganglioneuromatous differentiation of rhabdomyosarcoma: malignant ectomesenchymoma in an infant.
    Sebire NJ; Ramsay AD; Malone M; Risdon RA
    Pediatr Dev Pathol; 2003; 6(1):94-6. PubMed ID: 12469232
    [No Abstract]   [Full Text] [Related]  

  • 18. Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian collaborative study group for Ewing sarcoma family tumors-EWING1.
    Brunetto AL; Castillo LA; Petrilli AS; Macedo CD; Boldrini E; Costa C; Almeida MT; Kirst D; Rodriguez-Galindo C; Pereira WV; Watanabe FM; Pizza M; Benites E; Morais V; Gadelha A; Nakasato A; Abujamra AL; Gregianin LJ;
    Pediatr Blood Cancer; 2015 Oct; 62(10):1747-53. PubMed ID: 25917418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 43 year old male with a right pelvic mass.
    Carrasco Cubero C; Jiménez Arjona J; Michán Doña A
    Reumatol Clin; 2012; 8(4):225-6. PubMed ID: 22440360
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intensive chemotherapy for alveolar soft part sarcoma with lung metastasis in a child].
    Hibi S; Naya M; Takaya K; Morimoto M; Kataoka Y; Todo S; Imashuku S
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1249-52. PubMed ID: 8333754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.